Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Pantoprazole Sodium for Injection, 40mg per vial
Section 19A approved medicine
(Approval lapsed) Pantoprazole Sodium for Injection, 40mg per vial
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
PANTOPRAZOLE SANDOZ pantoprazole (as sodium) 40mg powder for injection vial - ARTG 147377
PANTOPRAZOLE SUN pantoprazole (as sodium) 40mg powder for injection vial - ARTG 172172
PANTOPRAZOLE SUN pantoprazole (as sodium) 40mg powder for injection vial - ARTG 172172
Indication(s)
For short-term use where oral therapy is not appropriate for the following conditions:
- Symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion, e.g. duodenal ulcer, gastric ulcer, reflux oesophagitis, gastrointestinal lesions refractory to H2 blockers, Zollinger-Ellison Syndrome.
- Maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis.
Note: Patients whose gastric or duodenal ulceration is not associated with ingestion of nonsteroidal anti-inflammatory drugs require treatment with antimicrobial agents in addition to antisecretory medicines, whether on first presentation or recurrence